<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://priyalifescience.com/article/sellas-regal-phase-3-galinpepimut-s-aml-overall-survival-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T17:00:01+00:00</news:publication_date>
      <news:title>SELLAS Says AML Vaccine GPS Extended Survival in Phase 3</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/weight-loss-drugs-uk-grocery-spending-worldpanel-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T15:00:02+00:00</news:publication_date>
      <news:title>Weight-Loss Drugs Cut UK Grocery Spending by Over £1bn</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-gsk-nelkarmi-neladalkib-alk-lung-cancer-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T13:00:02+00:00</news:publication_date>
      <news:title>FDA Approves GSK's Nelkarmi for ALK-Positive Lung Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-sanofi-infilbray-gaucher-disease-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T11:00:03+00:00</news:publication_date>
      <news:title>FDA Approves Sanofi's Infilbray for Type 3 Gaucher Disease</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/regeneron-ireland-profits-2025-accounts</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-21T08:30:02+00:00</news:publication_date>
      <news:title>Regeneron Ireland Profits Rise 20% to $4.91bn in 2025</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-regeneron-livsayis-cemdisiran-myasthenia-gravis-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T17:00:02+00:00</news:publication_date>
      <news:title>FDA Approves Regeneron's Livsayis for Myasthenia Gravis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-roche-wilserdly-giredestrant-esr1-breast-cancer-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T15:00:01+00:00</news:publication_date>
      <news:title>FDA Approves Roche Wilserdly for ESR1-Mutated Breast Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-clears-medtronic-hugo-robot-general-surgery-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T13:00:02+00:00</news:publication_date>
      <news:title>FDA Clears Medtronic's Hugo Robot for General Surgery</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/ireland-antibiotic-use-eu-ranking-ecdc-data-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T11:00:02+00:00</news:publication_date>
      <news:title>Irish Antibiotic Use Among EU's Highest, ECDC Data Show</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://priyalifescience.com/article/fda-approves-novartis-cosentyx-secukinumab-polymyalgia-rheumatica-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Priya Life Science</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-11-20T08:30:01+00:00</news:publication_date>
      <news:title>FDA Approves Cosentyx for Polymyalgia Rheumatica in Adults</news:title>
    </news:news>
  </url>
</urlset>